Form 4: Curtiss-Wright CFO Sells Shares Under 10b5-1 Plan

K. Christopher Farkas, Executive VP and CFO of Curtiss-Wright Corporation, sold 1,265 shares of common stock for an average price of $689.69 per share.

Summary

• K. Christopher Farkas, Executive VP and CFO of Curtiss-Wright Corporation (CW), sold 1,265 shares of common stock.
• The transaction occurred on March 18, 2026.
• The shares were sold at an average price of $689.69, with individual sales ranging from $681.18 to $699.31.
• The sale was executed under a Rule 10b5-1 trading plan adopted by Mr. Farkas on November 10, 2025.
• Following this transaction, Mr. Farkas beneficially owns 4,253 shares of Curtiss-Wright common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it's an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates concerns about its implications for the company's immediate prospects.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be interpreted by investors as a lack of conviction in the company's near-term stock price appreciation, though this is mitigated by the pre-planned nature.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider sales executed under a Rule 10b5-1 trading plan are generally viewed with less concern than open market sales, as these plans are established in advance when the insider is not in possession of material non-public information. This practice is common among executives for personal financial planning and diversification.

Stakeholder Impact

• Shareholders: Minor impact. The sale is a routine insider transaction under a pre-arranged plan, unlikely to signal significant changes in company fundamentals.

Key Dates

Recommendation

This Form 4 filing reports a routine insider sale executed under a Rule 10b5-1 trading plan. Such transactions are typically for personal financial management and do not usually indicate a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this disclosure. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information to alter an existing investment thesis.

Keywords

Curtiss-Wright, CW, insider trading, Form 4, stock sale, 10b5-1 plan, executive compensation, corporate governance